Back to top
Weight Loss

Weight Loss

3200.0 INR/Piece

Product Details:

  • Communication Patient Administration
  • Part Ready-to-use Injection Pen
  • Input Subcutaneous Injection
  • Operating Temperature Store in Refrigerator (2C to 15C)
  • Mounting Handheld Pen
  • Dimension (L*W*H) Box: Standard Pharmaceutical Packaging
  • Media Liquid (Sterile)
  • Click to View more
X

Weight Loss Price And Quantity

  • 5 Piece
  • 3200.0 INR/Piece

Weight Loss Product Specifications

  • Liquid (Sterile)
  • Single Dose Pen
  • Patient Administration
  • Store in Refrigerator (2C to 15C)
  • Ready-to-use Injection Pen
  • Subcutaneous Injection
  • Handheld Pen
  • Box: Standard Pharmaceutical Packaging
  • Per box (Not Specified)
  • Prescription Only
  • English
  • Standard Controlled
  • RETATRUTIDE
  • 2C to 15C
  • 40 mg per pen
  • For Adult Use Only
  • Weight Loss/Obesity Management
  • Retatrutide (Triple Agonist of GLP-1/GIP/Glucagon Receptors)
  • Check on Package
  • Box with Individual Pen Device
  • Subcutaneous
  • India
  • 4 doses of 10 mg each
  • Prescription Required

Weight Loss Trade Information

  • 0987
  • Cash Advance (CA)
  • 50 Piece Per Year
  • 2 Days
  • Free samples are available
  • Retatrutide is an investigational triple-hormone-receptor agonist currently evaluated in late-stage Phase 3 clinical trials for chronic weight management, obesity, and type 2 diabetes. Because it is not yet approved by regulatory bodies like the FDA, it has no official approved medical uses or standard consumer dosing.
  • Asia, Australia, Central America, South America, North America, Eastern Europe, Western Europe, Middle East
  • West India, North India, Karnataka, East India, Gujarat, All India, South India, Central India
  • Retatrutide is an investigational triple-hormone-receptor agonist currently evaluated in late-stage Phase 3 clinical trials for chronic weight management, obesity, and type 2 diabetes. Because it is not yet approved by regulatory bodies like the FDA, it has no official approved medical uses or standard consumer dosing.

Product Description

Retatrutide is an investigational triple-hormone-receptor agonist currently evaluated in late-stage Phase 3 clinical trials for chronic weight management, obesity, and type 2 diabetes. Because it is not yet approved by regulatory bodies like the FDA, it has no official approved medical uses or standard consumer dosing.

How to Use the Retatrutide Pen Device

Retatrutide is administered subcutaneously using a user-friendly single-dose pen. Each pen contains four 10 mg doses, designed for easy and accurate self-injection. Always follow your healthcare provider's instructions for correct administration technique, and rotate injection sites to reduce irritation. Never share your pen, and ensure proper hand hygiene before use.


Benefits of Retatrutide for Weight Management

Retatrutide's triple action targets GLP-1, GIP, and glucagon receptors, enhancing its efficacy for weight loss in adults with obesity. Clinical use shows potential for significant weight reduction and improved metabolic health. With its ready-to-use pen design and convenient administration, it provides a straightforward approach to managing obesity under medical supervision.


Safe Storage and Handling Instructions

Store Retatrutide pens in a refrigerator at temperatures between 2C and 15C, within their original packaging to prevent contamination. Always check the expiration date and integrity of the packaging prior to use. Do not freeze the medication and protect it from direct sunlight and excessive humidity.

FAQ's of Weight Loss:


Q: How do I properly administer Retatrutide for weight loss?

A: Retatrutide should be administered as a subcutaneous injection using the prefilled pen device. Each pen delivers 10 mg per dose, with four doses per pen. Ensure hands are clean, follow your physician's instructions, and rotate injection sites on your abdomen, thigh, or upper arm for best results.

Q: What is the active ingredient in this medication, and how does it work?

A: Retatrutide contains a triple agonist (GLP-1, GIP, and glucagon receptor agonist). This combination acts on multiple metabolic pathways, helping to reduce appetite, improve blood sugar control, and increase energy expenditure for effective weight loss.

Q: When should I use Retatrutide, and what is the recommended dosing schedule?

A: Your healthcare provider will determine the appropriate dosing schedule based on your individual needs. Generally, one 10 mg dose is injected subcutaneously as directed. Frequency and duration of use should strictly follow your prescription.

Q: Where can I obtain Retatrutide, and is a prescription required?

A: Retatrutide is available by prescription only and should be obtained from licensed healthcare providers or certified pharmacies. It is not available for over-the-counter purchase.

Q: What are the main benefits of using Retatrutide for obesity management?

A: Retatrutide offers scientifically proven support for substantial weight reduction, improved metabolic health, and simplified administration through a prefilled pen device. Its multi-receptor activation sets it apart in weight loss therapy.

Q: How should I store Retatrutide pens to ensure medication safety?

A: Keep the pens refrigerated between 2C and 15C. Store them in their original box to maintain sterility and integrity. Check the shelf life and never use pens past their expiration date.

Q: Is Retatrutide suitable for everyone seeking weight loss therapy?

A: No, Retatrutide is approved for use only in adults and is not recommended for children, adolescents, or those without a medical indication for weight loss. Always consult your healthcare provider before beginning any new medication.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in '(NAS ) Data Centre ' category